The Role of Hypothalamic H3 Histamine Receptors in Regulation of Striatal Function
下丘脑 H3 组胺受体在纹状体功能调节中的作用
基本信息
- 批准号:10534998
- 负责人:
- 金额:$ 6.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAllergicAllergic inflammationAutoreceptorsBehavioralBiological Response ModifiersBrainCellsCorpus striatum structureDiseaseDown-RegulationExhibitsFutureGeneticHistamineHistamine H3 ReceptorsHistamine ReceptorHistidine DecarboxylaseHyperactivityHypothalamic structureImmuneImmune responseImmune signalingInvestigationKnockout MiceLinkMediatingMediator of activation proteinMusNeuronsNeurotransmittersObsessive-Compulsive DisorderOrganPathologyPeripheralPhenotypeProcessReceptor ActivationRegulationRoleSchizophreniaSystemTestingUp-RegulationWild Type MouseWorkautism spectrum disorderepidemiology studygamma-Aminobutyric Acidmammilloinfundibular nucleus structuremast cellneuropsychiatric disorderoverexpressionreceptorreceptor upregulationrelating to nervous systemsmall hairpin RNAtargeted delivery
项目摘要
Allergic inflammation is associated with a number of neuropsychiatric disorders exhibiting striatal
dysregulation, including autism, obsessive-compulsive disorder, and schizophrenia. However, the
mechanisms underlying these links remain unknown. One possible influence on striatal function is the
peripheral immune mediator histamine. Histamine is not only a key mediator of the allergic immune response,
but is also a central neurotransmitter. Neurotransmitter histamine is produced solely by the posterior
tuberomammillary nucleus (TMN) of the hypothalamus. Histaminergic neurons co-release GABA; they
innervate the striatum, where they maintain tonic inhibition to suppress striatal hyperactivity.
An observation in a genetic mouse line lacking histamine, the histidine decarboxylase (Hdc) knockout mouse,
suggests a possible connection between systemic histamine and striatal activity. Hdc-KO mice exhibit
upregulation of the histamine autoreceptor H3R, particularly in the TMN, and have greater baseline neuronal
activity in the striatum. Systemic activation of the H3R receptor promotes further enhanced striatal activity. In
wild-type mice, chemogenetic silencing of the TMN also enhanced striatal activity. The hypothalamus is
surrounded by circumventricular organs which allow relatively free passage of systemic immune signals, such
as histamine. We hypothesize that systemic histamine directly modulates TMN activity via H3R and thereby
regulates downstream activity in the striatum.
The first Aim tests whether H3R upregulation in the TMN in Hdc-KO mice mediates the effects of systemic
administration of the H3R agonist RAMH on striatal activity. This will inform future work exploring the effects of
histamine derived from mast cells and other allergic immune cells within the hypothalamus on TMN and striatal
activity. Targeted delivery of RAMH to the TMN will test the sufficiency of TMN H3R activation to induce striatal
hyperactivity, and shRNA-targeted downregulation of H3R in the TMN will test the necessity of these receptors
in mediating striatal hyperactivity after systemic RAMH in both WT and Hdc-KO mice. The second Aim tests
whether overexpression of H3R in the TMN is sufficient to recapitulate the striatal activity phenotype observed
in Hdc-KO mice, which would further support the importance of hypothalamic H3R in modulating striatal activity
phenotypes. Finally, in Aim 3, I test whether allergic inflammation affects neural activity in the TMH and the
striatum, and whether this is mediated by hypothalamic H3R.
This work will lay the groundwork for further investigations of immune control of the TMN and downstream
brain targets, with potential relevance to a wide spectrum of neuropsychiatric disorders.
过敏性炎症与许多表现为纹状体的神经精神障碍有关
调节失调,包括自闭症、强迫症和精神分裂症。然而,
这些联系背后的机制仍不清楚。对纹状体功能的一个可能的影响是
外周免疫调节剂组胺。组胺不仅是过敏性免疫反应的关键介质,
但也是一种中枢神经递质。神经递质组胺仅由后脑产生
下丘脑结节乳头状核(TMN)。组胺能神经元共同释放GABA;它们
支配纹状体,在那里它们保持紧张性抑制,以抑制纹状体的过度活动。
在一种缺乏组胺的遗传性小鼠系,组氨酸脱羧酶(HDC)基因敲除小鼠中进行了观察,
提示全身性组胺和纹状体活动之间可能存在联系。HDC-KO小鼠展示
组胺自身受体H3R上调,特别是在TMN,并具有更多的基线神经元
纹状体中的活动。H3R受体的全身性激活促进纹状体活动的进一步增强。在……里面
野生型小鼠的TMN化学发生沉默也增强了纹状体的活动。下丘脑是
被室周器官包围,这些器官允许系统免疫信号相对自由地通过,如
是组胺。我们假设全身性组胺通过H3R直接调节TMN活性,从而
调节纹状体中的下游活动。
第一个目的是测试HDC-KO小鼠TMN中H3R的上调是否介导了全身性
给予H3R激动剂RAMH对纹状体活动的影响。这将为今后探索的影响提供参考
下丘脑肥大细胞和其他过敏性免疫细胞在TMN和纹状体上的组胺
活动。靶向向TMN输送RAMH将测试TMN H3R激活是否足以诱导纹状体
过度活跃和shRNA靶向下调TMN中的H3R将测试这些受体的必要性
在调节WT和HDC-KO小鼠全身性RAMH后纹状体过度活动方面。第二个目标测试
H3R在TMN中的过度表达是否足以概括所观察到的纹状体活动表型
在HDC-KO小鼠中,这将进一步支持下丘脑H3R在调节纹状体活动中的重要性
表型。最后,在目标3中,我测试了过敏性炎症是否影响TMH和
纹状体,以及这是否由下丘脑H3R介导。
这项工作将为进一步研究TMN及其下游的免疫调控奠定基础
大脑靶点,与广泛的神经精神障碍有潜在的相关性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher Fields其他文献
Christopher Fields的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher Fields', 18)}}的其他基金
The Role of Hypothalamic H3 Histamine Receptors in Regulation of Striatal Function
下丘脑 H3 组胺受体在纹状体功能调节中的作用
- 批准号:
10685282 - 财政年份:2022
- 资助金额:
$ 6.98万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 6.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 6.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 6.98万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 6.98万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 6.98万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 6.98万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 6.98万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 6.98万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 6.98万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 6.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)